Owl Creek Asset Management’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-49,998
Closed -$501K 199
2022
Q4
$501K Hold
49,998
0.02% 128
2022
Q3
$491K Hold
49,998
0.02% 144
2022
Q2
$490K Hold
49,998
0.02% 151
2022
Q1
$488K Hold
49,998
0.02% 166
2021
Q4
$487K Hold
49,998
0.03% 198
2021
Q3
$486K Hold
49,998
0.02% 186
2021
Q2
$487K Buy
+49,998
New +$486K 0.02% 187

Other funds holding COCH

Owl Creek Asset Management's COCH Position: Q1 2023 in Review

Owl Creek Asset Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 49,998 shares — an estimated $501K sold.

Owl Creek Asset Management first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $501K in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Owl Creek Asset Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Owl Creek Asset Management sold 49,998 Envoy Medical shares in Q1 2023, an estimated $501K.
  • Owl Creek Asset Management first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • Owl Creek Asset Management's Envoy Medical position peaked at $501K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Owl Creek Asset Management's 13F filing for Q1 2023, filed 15 May 2023.